ChromoTek’s fluorescent two hybrid (F2H®) technology enables screening and validation of compounds in living cells
more
Push For Smart Industry: ChromoTek wins category "Biotechnology" and the overall first prize from 1200 participating companies.
moreVisit us at the annual meeting of the American Association for Cancer Research, booth 1038!
moreChromoTek's Chromobody® Technology for High Content drug profiling licensed to Bayer
moreFAQs
-
Which GFP variants does the GFP-Trap® recognize?
-
- eGFP, wtGFP, GFP S65T
- TagGFP
- eYFP, YFP, Venus, Citrin
- CFP
Not recognized:
- TurboGFP
- all RFPs
-
Which RFP variants does the RFP-Trap® recognize?
-
- mRFP
- mCherry
- mOrange
- mPlum
- mRuby
- mKate2
Not recognized:
- DsRed
- mRFPruby
- TagRFP
- all GFPs
-
What is the binding capacity of the Nano-Trap (GFP-Trap®/ RFP-Trap®)?
-
That depends on the beads. Agarose beads usually bind 2-3 µg GFP per 10 µl slurry, the magnetic particles around 0.25 - 0.5 µg per 10 µl slurry.
-
Will I be able to elute bound proteins from the GFP-Trap®?
-
For quantitative elution you can either boil the sample for 10 minutes at 95° C in SDS sample buffer (see protocol) or incubate for 0.5 to 2 minutes in 0.2M glycine pH 2.5, followed by neutralization with 1/10 vol 1M Tris base.
-
Is it possible to elute bound proteins from the GFP-Trap® in their native state, e.g. for gel shift experiments or functional assays?
-
You may try to elute with free GFP. However, please be aware that this method will not quantitatively elute your fusion protein of interest.
-
How can I avoid unspecific protein interactions binding to the GFP-Trap®?
-
The critical step is to dilute the concentration of the detergent in the incubation buffer. We recommend a final concentration of 0.1% of the detergent (e.g. NP-40 or TX-100) and a final volume of at least 0.4 ml. In addition we recommend to test various salt concentrations in the wash buffer (e.g. 150 mM - 500 mM NaCl) to remove unspecifically bound hydrophilic proteins.
-
Will the eluted GFP binding protein cross-react with a secondary Ig specific antibody that is used to detect an antigen-specific first antibody?
-
Since the binding protein used in the GFP-Trap® does not have any significant homology with goat, mouse, rat or human antibodies, unspecific reactions with a secondary Ig specific antibody should not occur.
-
Is there a difference in binding when I use N-terminal vs. C-terminal GFP fusions?
-
The GFP-Trap® has a slightly higher affinity for C-terminal GFP-fusions. You can compensate this by an elongated incubation time ( 1 - 2 h instead of 15 - 30 min)
-
Can I purify GFP labeled fusion proteins directly from tissue samples, i.e. in a denaturing buffer?
-
In principle the GFP-Trap® is very stable even under harsh buffer conditions (e.g. RIPA buffer containing 0.1% SDS or 1M urea)
-
Is there a size limit for GFP labeled structures that can bind to the beads of the GFP-Trap®?
-
No.
-
What should I do if there is residual background in my eluates?
-
We recommend to use our blocked particles (bab-20 or bmp-20) to preclear your samples.
-
What is the difference between a Nanobody and your GFP-Trap®?
-
Nanobodies are antibody-derived therapeutic proteins that contain the unique structural and functional properties of naturally-occurring heavy-chain antibodies, developed by Belgian company Ablynx.
While the GFP-Trap® is also derived from heavy-chain antibodies, we do not call it GFP nanobody, since nanobodies are therapeutic proteins. GFP-Trap® in contrast is your premier tool for biochemical studies of your GFP fusion proteins.

